Last update :
17/12/2025
References   References 3352  
Type : Manufacturer

Research teams :
Authors :
Title : Ipilimumab (Yervoy®) - Summary of Product Characteristics
Reference : Bristol Myers Squibb 2011

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionIpilimumab Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Glass Sodium chloride 0,9% 1 >> 4 mg/ml 25°C Not specified
24 Hour
Stability in solutions Glass Glucose 5% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Glass Glucose 5% 1 >> 4 mg/ml 25°C Not specified
24 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 1 >> 4 mg/ml 25°C Not specified
24 Hour
Stability in solutions Polyvinyl chloride Glucose 5% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Polyvinyl chloride Glucose 5% 1 >> 4 mg/ml 25°C Not specified
24 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 1 >> 4 mg/ml 25°C Not specified
24 Hour
Stability in solutions Polyolefine Glucose 5% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Polyolefine Glucose 5% 1 >> 4 mg/ml 25°C Not specified
24 Hour
Compatible + Sodium chloride 0,9%
Compatible + Glucose 5%

  Mentions Légales